Hepatotoxicity due to lysine salt of bendazac

被引：3

作者：

Alcalde, M ^{[1
]}

GarciaDiaz, M ^{[1
]}

Najarro, F ^{[1
]}

Donoso, MS ^{[1
]}

Cebria, L ^{[1
]}

Pascasio, JM ^{[1
]}

机构：

[1] UNIV EXTREMADURA,INFANTA CRISTINA UNIV HOSP,DEPT GASTROENTEROL,BADAJOZ,SPAIN

来源：

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 1996年 / 31卷 / 02期

关键词：

anemia; cataracts; cholestasis; chronic active hepatitis; hepatotoxicity; lysine salt of bendazac;

D O I：

10.3109/00365529609031987

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background: The lysine salt of bendazac is a non-steroidal anti-inflammatory agent, and it is marketed exclusively for the treatment of cataracts. We report two cases of possible hepatotoxicity due to the use of bendazac lysine. Methods: Laboratory tests, serologic tests, abdominal sonography and scan were performed to study liver disease. Results: Reversible increases of the hepatic enzymes were found in both cases. Anemia was also found in one of the cases (case 1). Conclusions: Abnormal liver test results could be related to a possible liver injury attributed to the use of bendazac lysine.

引用

页码：206 / 208

页数：3

共 15 条

[1] BENDAZAC LYSINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF CATARACTS [J].

BALFOUR, JA ;

CLISSOLD, SP .

DRUGS, 1990, 39 (04) :575-596

[2]

BALLESTEROS JA, 1987, LANCET, V2, P1030

[3]

BONOMI L, 1983, CURR THER RES CLIN E, V33, P727

[4]

BRUGUERA H, 1993, GASTROENTEROLHEPATOL, V16, P357

[5]

Cancelo Suarez P, 1992, Med Clin (Barc), V99, P238

[6]

DEPAULO JP, 1993, MED CLIN-BARCELONA, V20, P48

[7]

FURET Y, 1985, ANN GASTROENTEROL HE, V1, P431

[8] DRUGS AND THE AGING LIVER [J].

JAMES, OFW .

JOURNAL OF HEPATOLOGY, 1985, 1 (04) :431-435

[9] DRUG-INDUCED HEPATOTOXICITY [J].

KAPLOWITZ, N ;

AW, TY ;

SIMON, FR ;

STOLZ, A .

ANNALS OF INTERNAL MEDICINE, 1986, 104 (06) :826-839

[10]

KROMANANDERSEN H, 1955, DAN MED B, V2, P187

← 1 2 →